• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

腹泻相关性溶血尿毒综合征中的糖尿病:一项系统评价和荟萃分析。

Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis.

作者信息

Suri Rita S, Clark William F, Barrowman Nick, Mahon Jeffrey L, Thiessen-Philbrook Heather R, Rosas-Arellano M Patricia, Zarnke Kelly, Garland Jocelyn S, Garg Amit X

机构信息

Kidney Clinical Research Unit, Division of Nephrology, London Health Sciences Center, University of Western Ontario, Room ELL-111 Victoria Hospital, 800 Commissioners Rd. East, London, Ontario, Canada N6A 4G5.

出版信息

Diabetes Care. 2005 Oct;28(10):2556-62. doi: 10.2337/diacare.28.10.2556.

DOI:10.2337/diacare.28.10.2556
PMID:16186301
Abstract

OBJECTIVE

To quantify the incidence of diabetes during the acute phase of diarrhea-associated hemolytic uremic syndrome (D + HUS) and to identify features associated with its development.

RESEARCH DESIGN AND METHODS

A systematic review and meta-analysis of articles assessing diabetes during D + HUS was conducted. Relevant citations were identified from Medline, Embase, and Institute for Scientific Information Citation Index databases. Bibliographies of relevant articles were hand searched. All articles were independently reviewed for inclusion and data abstraction by two authors.

RESULTS

Twenty-one studies from six countries were included. Only 2 studies reported a standard definition of diabetes; 14 defined diabetes as hyperglycemia requiring insulin. The incidence of diabetes during the acute phase of D + HUS could be quantified in a subset of 1,139 children from 13 studies (1966-1998, age 0.2-16 years) and ranged from 0 to 15%, with a pooled incidence of 3.2% (95% CI 1.3-5.1, random-effects model, significant heterogeneity among studies, P = 0.007). Children who developed diabetes were more likely to have severe disease (e.g., presence of coma or seizures, need for dialysis) and had higher mortality than those without diabetes. Twenty-three percent of those who developed diabetes acutely died, and 38% of survivors required long-term insulin (median follow-up 12 months). Recurrence of diabetes was possible up to 60 months after initial recovery.

CONCLUSIONS

Children with D + HUS should be observed for diabetes during their acute illness. Consideration should be given to long-term screening of D + HUS survivors for diabetes.

摘要

目的

量化腹泻相关性溶血尿毒综合征(D+HUS)急性期糖尿病的发病率,并确定其发生相关特征。

研究设计与方法

对评估D+HUS期间糖尿病的文章进行系统评价和荟萃分析。从医学文献数据库(Medline)、荷兰医学文摘数据库(Embase)和科学信息研究所引文索引数据库中识别相关引文。对相关文章的参考文献进行手工检索。所有文章由两位作者独立评审以确定是否纳入及进行数据提取。

结果

纳入了来自6个国家的21项研究。只有2项研究报告了糖尿病的标准定义;14项将糖尿病定义为需要胰岛素治疗的高血糖症。在13项研究(1966 - 1998年,年龄0.2 - 16岁)的1139名儿童亚组中可以量化D+HUS急性期糖尿病的发病率,范围为0至15%,合并发病率为3.2%(95%CI 1.3 - 5.1,随机效应模型,研究间存在显著异质性,P = 0.007)。发生糖尿病的儿童更可能患有严重疾病(如昏迷或惊厥、需要透析),且死亡率高于未患糖尿病的儿童。急性发生糖尿病的患儿中有23%死亡,38%的幸存者需要长期胰岛素治疗(中位随访12个月)。糖尿病在初次恢复后长达60个月都有可能复发。

结论

D+HUS患儿在急性发病期间应观察是否发生糖尿病。应考虑对D+HUS幸存者进行糖尿病的长期筛查。

相似文献

1
Diabetes during diarrhea-associated hemolytic uremic syndrome: a systematic review and meta-analysis.腹泻相关性溶血尿毒综合征中的糖尿病:一项系统评价和荟萃分析。
Diabetes Care. 2005 Oct;28(10):2556-62. doi: 10.2337/diacare.28.10.2556.
2
Long-term renal prognosis of diarrhea-associated hemolytic uremic syndrome: a systematic review, meta-analysis, and meta-regression.腹泻相关性溶血尿毒综合征的长期肾脏预后:一项系统评价、荟萃分析和元回归分析
JAMA. 2003 Sep 10;290(10):1360-70. doi: 10.1001/jama.290.10.1360.
3
Sertindole for schizophrenia.用于治疗精神分裂症的舍吲哚。
Cochrane Database Syst Rev. 2005 Jul 20;2005(3):CD001715. doi: 10.1002/14651858.CD001715.pub2.
4
Home treatment for mental health problems: a systematic review.心理健康问题的居家治疗:一项系统综述
Health Technol Assess. 2001;5(15):1-139. doi: 10.3310/hta5150.
5
Prophylactic mastectomy for the prevention of breast cancer.预防性乳房切除术用于预防乳腺癌。
Cochrane Database Syst Rev. 2004 Oct 18(4):CD002748. doi: 10.1002/14651858.CD002748.pub2.
6
Antibody tests for identification of current and past infection with SARS-CoV-2.抗体检测用于鉴定 SARS-CoV-2 的现症感染和既往感染。
Cochrane Database Syst Rev. 2022 Nov 17;11(11):CD013652. doi: 10.1002/14651858.CD013652.pub2.
7
A rapid and systematic review of the clinical effectiveness and cost-effectiveness of topotecan for ovarian cancer.拓扑替康治疗卵巢癌的临床有效性和成本效益的快速系统评价。
Health Technol Assess. 2001;5(28):1-110. doi: 10.3310/hta5280.
8
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.在基层医疗机构或医院门诊环境中,如果患者出现以下症状和体征,可判断其是否患有 COVID-19。
Cochrane Database Syst Rev. 2022 May 20;5(5):CD013665. doi: 10.1002/14651858.CD013665.pub3.
9
Eliciting adverse effects data from participants in clinical trials.从临床试验参与者中获取不良反应数据。
Cochrane Database Syst Rev. 2018 Jan 16;1(1):MR000039. doi: 10.1002/14651858.MR000039.pub2.
10
Airway physical examination tests for detection of difficult airway management in apparently normal adult patients.气道体格检查用于检测表面上正常的成年患者的困难气道管理情况。
Cochrane Database Syst Rev. 2018 May 15;5(5):CD008874. doi: 10.1002/14651858.CD008874.pub2.

引用本文的文献

1
Duration of prodromal phase and severity of hemolytic uremic syndrome.前驱期持续时间和溶血尿毒综合征的严重程度。
Pediatr Nephrol. 2024 Jan;39(1):213-219. doi: 10.1007/s00467-023-06104-8. Epub 2023 Aug 1.
2
Factors affecting dialysis duration in children with Shiga toxin-producing Escherichia coli-associated hemolytic uremic syndrome.产志贺毒素大肠杆菌相关性溶血尿毒综合征患儿透析时间的影响因素。
Pediatr Nephrol. 2023 Aug;38(8):2753-2761. doi: 10.1007/s00467-022-05839-0. Epub 2023 Jan 27.
3
GlnH, a Novel Antigen That Offers Partial Protection against Verocytotoxigenic Infection.
GlnH,一种对产志贺毒素感染提供部分保护作用的新型抗原。
Vaccines (Basel). 2023 Jan 13;11(1):175. doi: 10.3390/vaccines11010175.
4
Diagnosis and Treatment for Shiga Toxin-Producing Associated Hemolytic Uremic Syndrome.产志贺样毒素大肠埃希菌相关性溶血尿毒综合征的诊断与治疗。
Toxins (Basel). 2022 Dec 23;15(1):10. doi: 10.3390/toxins15010010.
5
Hyperuricemia: an unrecognized risk factor for kidney-related sequelae in children with hemolytic uremic syndrome.高尿酸血症:溶血尿毒综合征患儿肾脏相关后遗症的一个未被认识的危险因素。
Pediatr Nephrol. 2023 May;38(5):1547-1557. doi: 10.1007/s00467-022-05753-5. Epub 2022 Oct 13.
6
Glucose Control in Post-hemolytic-Uremic Syndrome Diabetes: A New Approach Offered by Sensor-Augmented Pump Therapy.溶血尿毒综合征后糖尿病的血糖控制:传感器增强泵治疗提供的新方法。
Front Pediatr. 2022 May 30;10:882319. doi: 10.3389/fped.2022.882319. eCollection 2022.
7
Erythropoietin in children with hemolytic uremic syndrome: a pilot randomized controlled trial.儿童溶血尿毒综合征中红细胞生成素的应用:一项初步随机对照试验。
Pediatr Nephrol. 2022 Oct;37(10):2383-2392. doi: 10.1007/s00467-022-05474-9. Epub 2022 Feb 15.
8
Shiga Toxin-Associated Hemolytic Uremic Syndrome: Specificities of Adult Patients and Implications for Critical Care Management.志贺毒素相关性溶血尿毒综合征:成人患者的特点及对重症监护管理的影响。
Toxins (Basel). 2021 Apr 26;13(5):306. doi: 10.3390/toxins13050306.
9
Shiga Toxin-Associated Hemolytic Uremic Syndrome: A Narrative Review.志贺毒素相关性溶血尿毒综合征:一篇叙述性综述。
Toxins (Basel). 2020 Jan 21;12(2):67. doi: 10.3390/toxins12020067.
10
On the dynamics of the human endocrine pancreas and potential consequences for the development of type 1 diabetes.人类内分泌胰腺的动力学及其对 1 型糖尿病发展的潜在影响。
Acta Diabetol. 2020 Apr;57(4):503-511. doi: 10.1007/s00592-019-01420-8. Epub 2019 Sep 13.